Black Hawk Acquisition Corp deposited $150,000 into its trust account to extend the deadline for completing its initial business combination. The extension moves the deadline from October 22, 2026, to November 22, 2026.
Black Hawk Acquisition M&A Deal with Vesicor Therapeutics, Inc.
Black Hawk Acquisition Corporation shareholders approved its business combination with Vesicor Therapeutics, Inc. at an extraordinary general meeting. The approval includes the domestication of the company from the Cayman Islands to Delaware and the election of five directors to the post-combination board. This represents a status update on a pending merger as the SPAC moves toward closing the transaction.
Black Hawk Acquisition M&A Deal with Vesicor Therapeutics, Inc.
Black Hawk Acquisition Corp entered into a forward purchase agreement and subscription agreement with Meteora Select Trading Opportunities Master, LP to support its pending business combination with Vesicor Therapeutics. The agreement covers up to 1,350,000 shares and includes an OTC equity prepaid forward transaction to manage redemption levels and provide financing for the merger. Upon closing, the company will pay a prepayment amount from its trust account to Meteora based on the redemption price of the shares.
Black Hawk Acquisition Corporation has deposited $150,000 into its trust account to extend the deadline for completing its initial business combination. The extension moves the deadline by one month, from September 22, 2026, to October 22, 2026.